T T Andersen
Overview
Explore the profile of T T Andersen including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
68
Citations
384
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Dee K, Andersen T, Bizios R
Tissue Eng
. 2009 Nov;
1(2):135-45.
PMID: 19877922
This in vitro study examined the effects of soluble basic fibroblast growth factor and transforming growth factor-beta on bovine pulmonary artery endothelial cell interactions with surfaces containing the covalently-bound adhesive...
2.
Hunziker P, Andersen T, Bao Y, Cohen S, Denslow N, Hulmes J, et al.
J Biomol Tech
. 2009 Jun;
10(3):129-36.
PMID: 19499016
The ABRF amino acid analysis study evaluated the general utility of amino acid analysis (AAA) for identification of proteins after denaturing gel electrophoresis and electroblotting to polyvinylidene difluoride (PVDF) membrane.Thirty-eight...
3.
Andersen T, Georgekutty J, Defreest L, Amaratunga G, Narendran A, Lemanski N, et al.
Br J Cancer
. 2007 Jul;
97(3):327-33.
PMID: 17637684
Tamoxifen (Tam) is effective for the treatment and prevention of breast cancer. However, it has toxic drawbacks and has limited-duration utility because, over time, human tumours become refractory to Tam....
4.
Defreest L, Mesfin F, Joseph L, McLeod D, Stallmer A, Reddy S, et al.
J Pept Res
. 2004 May;
63(5):409-19.
PMID: 15140158
Asynthetic peptide that inhibits the growth of estrogen receptor positive (ER+) human breast cancers, growing as xenografts in mice, has been reported. The cyclic 9-mer peptide, cyclo[EMTOVNOGQ], is derived from...
5.
Hasenbein M, Andersen T, Bizios R
Biomaterials
. 2002 Aug;
23(19):3937-42.
PMID: 12162326
Microcontact printing techniques were used to pattern circles (diameters 10. 50, 100, and 200 microm) of N1[3-(trimethoxysilyl)-propyl]diethylenetriamine (DETA) surrounded by octadecyltrichlorosilane (OTS) borders on borosilicate glass, a model substrate. The...
6.
Mesfin F, Andersen T, Jacobson H, Zhu S, Bennett J
J Pept Res
. 2001 Sep;
58(3):246-56.
PMID: 11576331
The peptide, EMTPVNPG, derived from alpha-fetoprotein, inhibits estrogen-stimulated growth of immature mouse uterus and estrogen-dependent proliferation of human breast cancer cells. However, the biological activities of the peptide diminish over...
7.
Eisele L, Mesfin F, Bennett J, Andersen T, Jacobson H, Vakharia D, et al.
J Pept Res
. 2001 Jul;
57(6):539-46.
PMID: 11437957
A 34-amino acid portion of the third domain of alpha-fetoprotein possesses antigrowth and anticancer activities. Three analogs of this sequence were chemically synthesized, in which the two cysteines of the...
8.
Eisele L, Mesfin F, Bennett J, Andersen T, Jacobson H, Soldwedel H, et al.
J Pept Res
. 2001 Feb;
57(1):29-38.
PMID: 11168886
A 34-amino acid synthetic peptide was derived from the third domain of human alpha-fetoprotein, and the peptide was shown to inhibit estrogen-stimulated growth. Under certain conditions, however, the peptide lost...
9.
Line B, Feustel P, Festin S, Andersen T, Dansereau R, Lukasiewicz R, et al.
Cancer Biother Radiopharm
. 2000 Jun;
14(6):485-94.
PMID: 10850335
Because adenocarcinoma of the breast expresses receptors for alpha-fetoprotein (AFP), we studied Tc-99m AFP as a radiopharmaceutical to detect breast cancer. The biodistribution of Tc-99m radiolabeled natural human AFP (full...
10.
Mesfin F, Bennett J, Jacobson H, Zhu S, Andersen T
Biochim Biophys Acta
. 2000 Mar;
1501(1):33-43.
PMID: 10727847
Alpha-fetoprotein (AFP) is a major serum protein produced during fetal development. Experimental findings suggest that AFP has antiestrotrophic activity and that it can be developed as a therapeutic agent to...